Kazufumi Kawabata

Title: Kazufumi Kawabata: Innovator in Recombinant Cell Technology

Introduction

Kazufumi Kawabata is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant cells. His work focuses on the synthesis of isoprene and terpenes, which are vital compounds in various industrial applications.

Latest Patents

Kawabata holds a patent for a recombinant cell, method for producing recombinant cell, and method for producing isoprene or terpene. This innovative recombinant cell is designed to produce isoprene or terpene by synthesizing isopentenyl diphosphate through a mevalonate pathway (MVA pathway). Notably, the recombinant cell lacks the ability to synthesize isopentenyl diphosphate through an endogenous non-mevalonate pathway (MEP pathway). It incorporates an isoprene synthase gene or a terpene synthase gene as a foreign gene, enabling the production of isoprene or terpene with varying carbon atom counts, specifically 10, 15, 20, 30, or 40 carbon atoms. The mevalonate pathway utilized is preferably an exogenous mevalonate pathway.

Career Highlights

Kawabata is currently employed at Sekisui Chemical Co., Ltd., where he continues to advance his research and development efforts. His work has positioned him as a key figure in the field of synthetic biology and biotechnology.

Collaborations

Kawabata collaborates with talented individuals such as Kana Matsushima and Masahiro Furutani. These partnerships enhance the innovative potential of his projects and contribute to the advancement of their shared goals.

Conclusion

Kazufumi Kawabata's contributions to recombinant cell technology and his innovative approaches to producing isoprene and terpenes highlight his importance in the field of biotechnology. His work continues to pave the way for advancements in synthetic biology.